Last reviewed · How we verify
Custodiol
At a glance
| Generic name | Custodiol |
|---|---|
| Also known as | Custodiol (Eusa Pharma), htk, Bretschneider solution, HTK solution, Solution for organ preservation in transplantation |
| Sponsor | Scientific Institute San Raffaele |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children (PHASE2)
- Study of Organ Perfusion in Heart Transplantation in Children (PHASE2)
- Adding Lidocaine to Custodiol Mixture (PHASE4)
- Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas) (PHASE3)
- Evaluation of Clinical Impact of the Type of Cardioplegia Used in the Patient Undergoing Major Cardiac Surgery. (PHASE4)
- Modified Del Nido Versus Custodiol Cardioplegia For Myocardial Protection In Cardiac Surgery. (NA)
- Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery (PHASE2)
- Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Custodiol CI brief — competitive landscape report
- Custodiol updates RSS · CI watch RSS
- Scientific Institute San Raffaele portfolio CI